September 18, 2019

American CryoStem Announces:  FDA Accepted its Investigational New Drug Application for Post Concussion Syndrome

ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed via Intravenous Infusion for the Treatment of Post Concussion Syndrome (PCS) in Retired Military and Athletes EATONTOWN, NJ […]
September 12, 2019
American CryoStem starts Post-Concussion Syndrome clinical trials

American CryoStem Engages BioSolutions Clinical Research Center, LLC. and Principal Investigator for Chronic Concussive Syndrome IND

EATONTOWN, NJ / ACCESSWIRE / September 11, 2019 / American CryoStem Corporation (OTC PINK:CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular […]
August 22, 2019

American CryoStem Engages IRB for IND Filling with the FDA

March 20, 2019

American CryoStem Completes Cooperative Framework Agreement to Expand Market Presence in Japan

December 13, 2018

American CryoStem to file Investigational New Drug Application with FDA

December 5, 2018

American CryoStem Receives Final Patent to Complete its Core Cellular Platform

August 21, 2018

American CryoStem Announces Receipt of Key Business Method Patent for its Cellular Platform

July 12, 2018

American CryoStem Announces Launch of ATGRAFT in China

June 19, 2018

American CryoStem to Develop Standardized Tissue Scoring System

EATONTOWN, NJ / ACCESSWIRE / June 19, 2018 / American CryoStem Corporation (OTC PINK: CRYO), a leading strategic application developer, marketer, global licensor of patented adipose […]